Open AccessLoss of COP9 signalosome genes at 2q37 is associated with IMiD resistance in multiple myeloma
Author(s) -
Sarah Gooding,
Naser AnsariPour,
Mohammad H. Kazeroun,
Kübra Karagoz,
Ann Polonskaia,
Mirian Angulo Salazar,
Evie Fitzsimons,
Korsuk Sirinukunwattana,
Selina J Chavda,
María Ortiz Estévez,
Fadi Towfic,
Erin Flynt,
William E. Pierceall,
Daniel Royston,
Kwee Yong,
Karthik Ramasamy,
Paresh Vyas,
Anjan Thakurta
Publication year - 2022
Publication title -
blood
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.515
H-Index - 465
eISSN - 1528-0020
pISSN - 0006-4971
DOI - 10.1182/blood.2022015909
Subject(s) - cereblon , lenalidomide , pomalidomide , biology , genetics , multiple myeloma , cancer research , ubiquitin ligase , gene , immunology , ubiquitin
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom